ImmunoQure AG

Rare, natural autoantibodies derived from patients, for patients

ImmunoQure AG is a young biotech company spearheading the research & development of human-derived autoantibodies for the treatment of human diseases. Through our unique access to rare patient populations, we are able to correlate clinical status with serological profiles and subsequently clone autoantibodies which the patient’s own immune system has optimized against key drug targets involved in preventing a number of human diseases.

Science

See how the clinical status of rare patients lead us to identifying autoantibodies and the proteins they target as we learn from Nature about how to ameliorate human disease

People

Meet our team. We are an international group of researchers and entrepreneurs with a common goal: to create a new generation of drugs for the treatment of human diseases

News

Visit our media center and read about our latest achievements and discoveries.

Partners

ImmunoQure has a network of collaborations with industrial and academic partners that enable the development of our autoantibody-based drugs